(R)-1,2,3,4-tetrahedro-naphthoic acid is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of various bioactive compounds. Its stereospecific structure makes it valuable in the development of enantiomerically pure drugs, particularly those targeting neurological and cardiovascular diseases. Additionally, it serves as an intermediate in the production of complex organic molecules used in medicinal chemistry research. Its application extends to asymmetric synthesis, where it aids in creating compounds with high optical purity, essential for drug efficacy and safety.